| | **** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS **** 
 +----------------+--------------------------------------+----------+-----------+
 |      CAS#      |              Chemical Name           |    %     |  EINECS#  |
 |----------------|--------------------------------------|----------|-----------|
 |     3184-13-2  |L-(+)-Ornithine-Hydrochloride         |   >98%   | 221-678-6 |
 +----------------+--------------------------------------+----------+-----------+
 Hazard Symbols: None Listed.
 Risk Phrases: None Listed.
 
 **** SECTION 3 - HAZARDS IDENTIFICATION ****
 
 EMERGENCY OVERVIEW
 The toxicological properties of this material have not been fully
 investigated.
 
 Potential Health Effects
 Eye:
 No information regarding eye irritation and other potential effects
 was found.  Contact may cause transient eye irritation.
 Skin:
 May cause skin irritation. Low hazard for usual industrial handling.
 Ingestion:
 May cause irritation of the digestive tract. The toxicological
 properties of this substance have not been fully investigated.
 Inhalation:
 May cause respiratory tract irritation. The toxicological properties
 of this substance have not been fully investigated.
 Chronic:
 No information found.
 
 **** SECTION 4 - FIRST AID MEASURES ****
 
 Eyes:
 Flush eyes with plenty of water for at least 15 minutes,
 occasionally lifting the upper and lower eyelids. Get medical aid.
 Skin:
 Get medical aid. Flush skin with plenty of water for at least 15
 minutes while removing contaminated clothing and shoes. Get medical
 aid if irritation develops or persists. Wash clothing before reuse.
 Flush skin with plenty of soap and water.
 Ingestion:
 Never give anything by mouth to an unconscious person. Get medical
 aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
 drink 2-4 cupfuls of milk or water.
 Inhalation:
 Remove from exposure and move to fresh air immediately. If not
 breathing, give artificial respiration. If breathing is difficult,
 give oxygen. Get medical aid if cough or other symptoms appear.
 Notes to Physician:
 
 **** SECTION 5 - FIRE FIGHTING MEASURES ****
 
 General Information:
 As in any fire, wear a self-contained breathing apparatus in
 pressure-demand, MSHA/NIOSH (approved or equivalent), and full
 protective gear. Combustion generates toxic fumes. During a fire,
 irritating and highly toxic gases may be generated by thermal
 decomposition or combustion.
 Extinguishing Media:
 Use water spray, dry chemical, or carbon dioxide. Use agent most
 appropriate to extinguish fire. Use water spray, dry chemical, carbon
 dioxide, or appropriate foam.
 
 **** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
 
 General Information: Use proper personal protective equipment as indicated
 in Section 8.
 Spills/Leaks:
 Clean up spills immediately, observing precautions in the Protective
 Equipment section. Sweep up, then place into a suitable container for
 disposal. Avoid generating dusty conditions. Provide ventilation.
 
 **** SECTION 7 - HANDLING and STORAGE ****
 
 Handling:
 Wash thoroughly after handling. Remove contaminated clothing and
 wash before reuse. Use with adequate ventilation. Minimize dust
 generation and accumulation. Avoid contact with eyes, skin, and
 clothing. Keep container tightly closed. Avoid ingestion and
 inhalation.
 Storage:
 Store in a tightly closed container. Store in a cool, dry,
 well-ventilated area away from incompatible substances.
 
 **** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
 
 Engineering Controls:
 Facilities storing or utilizing this material should be equipped
 with an eyewash facility and a safety shower. Local exhaust may be
 necessary to control concentrations to acceptable levels.
 Exposure Limits
 CAS# 3184-13-2:
 
 
 Personal Protective Equipment
 
 Eyes:
 Wear appropriate protective eyeglasses or chemical
 safety goggles as described by OSHA's eye and face
 protection regulations in 29 CFR 1910.133 or European
 Standard EN166.
 Skin:
 Wear appropriate gloves to prevent skin exposure.
 Clothing:
 Wear appropriate protective clothing to prevent skin
 exposure.
 Respirators:
 Follow the OSHA respirator regulations found in 29
 CFR 1910.134 or European Standard EN 149. Use a
 NIOSH/MSHA or European Standard EN 149 approved
 respirator if exposure limits are exceeded or if
 irritation or other symptoms are experienced.
 
 **** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
 
 Physical State:             Solid
 Color:                      white
 Odor:                       None reported.
 pH:                         Not available.
 Vapor Pressure:             Negligible.
 Viscosity:                  Not available.
 Boiling Point:              Not available.
 Freezing/Melting Point:     245 deg C
 Autoignition Temperature:   Not applicable.
 Flash Point:                Not applicable.
 Explosion Limits, lower:    Not available.
 Explosion Limits, upper:    Not available.
 Decomposition Temperature:  >235 deg C
 Solubility in water:        543 G/L WATER (20 C)
 Specific Gravity/Density:
 Molecular Formula:          C5H12N2O2.HCl
 Molecular Weight:           168.62
 
 **** SECTION 10 - STABILITY AND REACTIVITY ****
 
 Chemical Stability:
 Stable under normal temperatures and pressures.
 Conditions to Avoid:
 High temperatures, incompatible materials, dust generation, excess
 heat.
 Incompatibilities with Other Materials:
 Oxidizing agents.
 Hazardous Decomposition Products:
 Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and
 toxic fumes and gases, carbon dioxide.
 Hazardous Polymerization: Has not been reported.
 
 **** SECTION 11 - TOXICOLOGICAL INFORMATION ****
 
 RTECS#:
 CAS# 3184-13-2: RM2985000
 LD50/LC50:
 CAS# 3184-13-2: Oral, rat: LD50 = 10 gm/kg.
 Carcinogenicity:
 L-(+)-Ornithine-Hydrochloride -
 Not listed by ACGIH, IARC, or NTP.
 Other:
 See actual entry in RTECS for complete information.
 
 **** SECTION 12 - ECOLOGICAL INFORMATION ****
 
 
 
 **** SECTION 13 - DISPOSAL CONSIDERATIONS ****
 
 Dispose of in a manner consistent with federal, state, and local regulations.
 
 **** SECTION 14 - TRANSPORT INFORMATION ****
 
 IATA
 Not regulated as a hazardous material.
 IMO
 Not regulated as a hazardous material.
 RID/ADR
 Not regulated as a hazardous material.
 
 **** SECTION 15 - REGULATORY INFORMATION ****
 
 European/International Regulations
 European Labeling in Accordance with EC Directives
 Hazard Symbols: Not available.
 Risk Phrases:
 Safety Phrases:
 S 24/25  Avoid contact with skin and eyes.
 WGK (Water Danger/Protection)
 CAS# 3184-13-2: 0
 Canada
 CAS# 3184-13-2 is listed on Canada's DSL List.
 CAS# 3184-13-2 is not listed on Canada's Ingredient Disclosure List.
 US FEDERAL
 TSCA
 CAS# 3184-13-2 is listed on the TSCA inventory.
 
 **** SECTION 16 - ADDITIONAL INFORMATION ****
 
 MSDS Creation Date:  9/02/1997  Revision #4 Date:  3/18/2003
 
 The information above is believed to be accurate and represents the best
 information currently available to us. However, we make no warranty of
 merchantability or any other warranty, express or implied, with respect to
 such information, and we assume no liability resulting from its use. Users
 should make their own investigations to determine the suitability of the
 information for their particular purposes. In no way shall the company be
 liable for any claims, losses, or damages of any third party or for lost
 profits or any special, indirect, incidental, consequential or exemplary
 damages, howsoever arising, even if the company has been advised of
 the possibility of such damages.
 --------------------------------------------------------------------------------
 --------------------------------------------------------------------------------
 
 |  | 
 | 
| 
| ALL MSDS PAGES IN THIS GROUP |  | | NAME | CAS |  
| 5-Formyl-2-furansulfonic acid, sodium salt, 98% | 31795-44-5 |  
| 1,10-Phenanthroline monohydrate, reagent ACS | 66-71-7 |  
| Phenol Red Sodium Salt, Reagent ACS | 34487-61-1 |  
| Phloxine B | 18472-87-2 |  
| (1-Aminohexyl)phosphonic acid, 97% | 63207-60-3 |  
| Pyruvic acid, sodium salt, 99+% | 113-24-6 |  
| (1-Amino-2-methylpropyl)phosponic acid, 97% | 18108-24-2 |  
| Rose bengal (cert) | 632-69-9 |  
| Safranin O certified | 477-73-6 |  
| (1-Amino-3-Methylbutyl)Phosphonic Acid, 97% | 20459-60-3 |  
| Diethyldithiocarbamic acid, sodium salt, trihydrate | 148-18-5 |  
| Sudan iii  (cert) | 85-86-9 |  
| Sudan IV  (Cert), 95% (UV-VIS) | 85-83-6 |  
| Sudan Black B (Cert), 99%  (UV-VIS) | 4197-25-5 |  
| Thenoyltrifluoroacetone, 99% | 326-91-0 |  
| Thionin (Cert) | 581-64-6 |  
| (1-Amino-2-methylbutyl)phosphonic acid, 97% | 20459-61-4 |  
| Toluidine Blue O (Cert) | 92-31-9 |  
| (1-Aminooctyl)phosphonic acid, 97% | 94219-58-6 |  
| tris-(Hydroxymethyl)-aminomethane  hydrochloride, 99+% | 1185-53-1 |  
| Brilliant Blue G | 6104-58-1 |  
| Ethidium Bromide, 95% | 1239-45-8 |  
| Ponceau S | 6226-79-5 |  
| Pyronin Y, certified | 92-32-0 |  
| Nitro BT, 85% (Titr.) | 298-83-9 |  
| (r,r)-Dithiothreitol, 98% (titr.) | 3483-12-3 |  
| Dithioerythritol, 95% (Titr.) | 6892-68-8 |  
| Guanidine Thiocyanate, 99% (Titr.) | 593-84-0 |  
| D(+)-Biotin, 98% | 58-85-5 |  
| 2-(4-Morpholino)ethanesulfonic Acid, 99% (titr.) | 4432-31-9 |  
| Diethylmethylphosphonate, 96% | 683-08-9 |  
| 2,2-Bis(Hydroxymethyl)-2,2',2"-Nitrilo- Triethanol, 99+% | 6976-37-0 |  
| ACES, 96% | 7365-82-4 |  
| HEPES, 99% | 7365-45-9 |  
| Tricine, 98+% | 5704-04-1 |  
| Caps (3-Cyclohexylamino-1-Propanesulfonic  Acid), 99% | 1135-40-6 |  
| 4'-Bromoacetanilide, 98% | 103-88-8 |  
| l-Isoleucine, 99% | 73-32-5 |  
| l-Leucine, 99% | 61-90-5 |  
| L-(+)-Ornithine-Hydrochloride, 99% | 3184-13-2 |  
| l-Threonine, 98% | 72-19-5 |  
| Benzamidine hydrochloride, 99% (titr.) | 1670-14-0 |  
| 2,3-Dihydrofuran, 98% | 1191-99-7 |  
| Ches 98+% | 103-47-9 |  
| FMOC-L-Asparagin Acid-Beta-T-Butylester, 98% | 71989-14-5 |  
| 2-Chloropyridine, 99% | 109-09-1 |  
| N,N'-Diisopropylcarbodiimide, 99% | 693-13-0 |  
| N,N-Diisopropylethylamine | 7087-68-5 |  
| 4-Dimethylaminopyridine, 99% | 1122-58-3 |  
| D-Pantothenic Acid Calcium Salt, 97.5-102.0% (from Calcium Content,on | 137-08-6 | 
 | 
 |